The effects were accompanied by a decreased survival of neuroblastoma cells, a decrease of the cytoplasmic level of MYCN oncogene, an increase in levels of P53 and downregulation of the AKT/mTOR network (Horwacik et al., 2013; Durbas et al., 2015). Here, MYCN is linked to neuroblastoma.